Related references
Note: Only part of the references are listed.Treatment-emergent CNS symptoms following triptan therapy are part of the attack
P. J. Goadsby et al.
CEPHALALGIA (2007)
Development and validation of the short version of the Psychological General Well-Being Index (PGWB-S)
Enzo Grossi et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2006)
Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls
E Loder et al.
CEPHALALGIA (2005)
Clarification of terminology in drug safety
JK Aronson et al.
DRUG SAFETY (2005)
Topiramate in migraine prevention - Results of a large controlled trial
SD Silberstein et al.
ARCHIVES OF NEUROLOGY (2004)
Topiramate for migraine prevention - A randomized controlled trial
JL Brandes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Systematic screening allows reduction of adverse antiepileptic drug effects - A randomized trial
FG Gilliam et al.
NEUROLOGY (2004)
Using item response theory to calibrate the Headache Impact Test (HIT™) to the metric of traditional headache scales
JB Bjorner et al.
QUALITY OF LIFE RESEARCH (2003)
Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy
MD Privitera et al.
ACTA NEUROLOGICA SCANDINAVICA (2003)
Low-dose topiramate in adults with treatment-resistant partial-onset seizures
A Guberman et al.
ACTA NEUROLOGICA SCANDINAVICA (2002)
Share Paper
